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Summary
Chronic rhinosinusitis (CRS) is an inflammation of the mucous membrane of the nose and paranasal sinuses. 
One of the four cardinal symptoms is smell distortion. It is estimated that CRS is the cause of 14 — 30% of 
all olfactory disorders among humans. A wide variety of methods checking olfactory functions have been 
developed. This literature review is meant to discuss all known up-to-date tests and show their usefulness. 
The authors also compare the results of treatment, according to the level of smell disorders, in connection 
with the presence of polyps, time of healing of post-operative wounds, time of the procedure, and others. 
In conclusion, one can say that all of these characteristics are important and that treatment of dysosmia 
is a challenging part of chronic sinusitis therapy.
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Introduction
Chronic rhinosinusitis (CRS) is inflammation of the 
mucous membrane of the nose and paranasal sinuses 
lasting for at least 12 weeks [1]. According to the current 
state of knowledge, CRS is caused by impaired drain-
age and ventilation of paranasal sinuses, which result 
from obstruction of the natural ostia. The predisposing 
factors are: abnormal anatomy, infections, allergies, im-
paired cilia mobility, laryngopharyngeal reflux, nodules, 
foreign bodies, a history of injuries, and hormonal and 
immunological disorders [2]. According to the latest 
estimates, the prevalence of CRS is from 5.5% to 10.9% 
[3–6]. In order to diagnose CRS as prescribed in the 
European Position Paper on Rhinosinusitis and Nasal 
Polyps (EPOS), at least two of four cardinal symptoms 
have to be diagnosed. At least one of two cardinal symp-
toms has to be present: either nasal discharge or nasal 
obstruction. The two remaining symptoms are smell 
distortion (dysosmia) and facial pain/pressure. Finding 
nasal polyps, presence of mucopurulent discharge, 
swelling in the middle nasal meatus, or obstruction 
found in physical examination, help to diagnose the 
CRS. In addition, CRS can be diagnosed upon finding 
inflammatory lesions of the mucous membrane in the 
ostiomeatal complex in a computed tomography (CT) 
scan. According to the EPOS, CRS with nasal polyps 
(CRSwNP) can be distinguished; it is diagnosed when 
polyps are present on both sides of the middle nasal 
meatus. They constitute less than 18% of all cases of 
CRS [3]. In other cases, CRS without nasal polyps 
(CRSsNP) is diagnosed [1].
The diagnostic methods commonly used to evaluate 
the severity of CRS at the local level are:
 — Computed Tomography (CT) with the use of the 
Lund Mackay scoring system. Each of the paranasal 
sinuses and ostiomeatal complexes is evaluated; 
each individual anatomical structure is assigned 
a score of 0–2. Each side is evaluated separately. 
A total score of 24 can be assigned [7–8].
 — Nasal endoscopy with the use of the Lund Kennedy 
scoring system. Evaluation includes the presence 
of polyps in the middle nasal meatus as well as 
discharge, swelling of the mucous membrane, 
scars/adhesions, and crusts in the nasal cavities 
[7–8]. Each of the identified factors is assigned 
a score of 0–2, separately for each of the sides. A to-
tal score of 20 can be assigned [7–8].
CRS decreases the quality of life and effectiveness 
of work [9]. Therefore, in view of the epidemiological 
data provided above, CRS is a serious health concern 
that requires effective treatment. The treatment of choice 
for CRS is pharmacological treatment; its specific 
course depends on the form and severity of the disease 
evaluated using a Visual Analogue Scale (VAS) and 
endoscopy. VAS is based on the patient self-assessing 
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the severity of symptoms of CRS. An analogue scale of 
0–10 is used, where the highest score indicated by the 
patient corresponds with the most severe symptoms 
of CRS. 
Treatment of CRS begins with topical steroid treat-
ment. In the case of CRSsNP, irrigation is additionally 
introduced. In the event of no improvement after three 
months or a more severe course of the disease identified 
based on the VAS or endoscopy, antibiotic therapy, 
as an extension of treatment, should be considered. 
If pharmacological treatment is not effective, surgical 
treatment should be considered. However, after surgical 
treatment, pharmacological treatment, i.e. irrigation and 
topical steroid therapy, and possibly general steroid and 
antibiotic therapy, should be continued [1].
Nowadays, the standard of surgical treatment of 
CRS is Functional Endoscopic Sinus Surgery (FESS). 
This procedure is based on eliminating the cause be-
hind the CRS by restoring correct ventilation and drain-
age of the sinuses. So far, surgical intervention within 
the area of the maxillary sinus is limited to nose side wall 
structures, i.e. resection of the uncinate process and, 
if there is a need to gain improved access to the maxil-
lary sinus, widening of its natural ostium. Frontal sinus 
surgery is, in most cases, limited to intervention within 
the area of the frontal recess. In the abovementioned 
cases of sinusitis or if inflammatory lesions occur in 
anterior ethmoid sinuses, the ethmoid cells are opened. 
Sphenoid sinusitis is usually treated by widening natural 
ostia of these sinuses. If ostia of the sinuses are hard to 
identify, artificial ostia are created. In the case of sphe-
noid sinusitis or posterior ethmoid sinusitis, posterior 
ethmoid cells have to be opened. According to different 
methods of approaching the frontal sinus, three basic 
types of procedure are identified: Draf I, Draf II a, Draf 
II b, and Draf III. The technique to be selected depends 
on the size of the inflammatory lesions, the need to 
remove lesions in the lumen of the sinus, and anatom-
ical conditions. The Draf I procedure involves draining 
the sinus without damaging its mucous membrane by 
removing a fragment of the uncinate process. In the Draf 
II a procedure, the sinus is approached by resection of 
bone trabeculae in the vicinity of its ostium and widening 
of the sinus ostium from the orbital plate to the vertical 
plate of the middle nasal concha. The Draf II b proce-
dure is based on complete removal of the bottom wall of 
the frontal sinus between the orbital plate and the nasal 
septum, including partial removal of the vertical plate 
of the middle nasal concha in its anterior segment. The 
most invasive approach to the frontal sinus is gained by 
using the Draf III technique, also called the endoscopic 
modified Lothrop procedure. This procedure is initiated 
by creating a Draf II b-type two-way approach and then 
resecting the upper anterior part of the nasal septum 
and the partition inside the frontal sinus. [2].
Examining olfactory dysfunctions in 
chronic rhinosinusitis
Olfactory dysfunction is diagnosed in 60 — 83% of 
cases of CRS [3,7,10–12]. It is estimated that CRS is 
the cause of 14 — 30% of all olfactory disorders and 
is the second most common cause of these disorders, 
the first being acute viral rhinitis and rhinosinusitis 
[5,7,13]. The pathophysiological basis of the olfactory 
dysfunction is the impairment of nose patency and 
inflammatory damage to the olfactory epithelium of the 
nasal cavities [10]. The most common olfactory disor-
ders include: anosmia — loss of the sense of smell, and 
hyposmia — partial impairment of the sense of smell. 
Other forms of improper function of the olfactory system, 
such as hyperosmia — olfactory hypersensitivity and 
olfactory hallucinations, i.e. smelling odours different 
from the real ones, are predominantly associated with 
psychiatric and neurological disorders related to the 
central nervous system [2]. It is important to note that 
the sense of smell, together with the sense of taste, 
plays an important role in the physiology of nutrition, 
is responsible for defence mechanisms, and has an 
effect on the quality of life [3,12]. In the case of olfacto-
ry disorders, it has been noted that the prevalence of 
psychosocial problems, e.g. depression, is higher when 
compared to the general population, and the quality of 
life is decreased [7,14].
A wide variety of methods checking olfactory func-
tions have been developed hitherto; their main aim is 
to detect quantitative olfactory dysfunctions. They differ 
in sensitivity, test duration, costs, complexity, the extent 
to which they are hard to understand for the patient, 
and type of tested olfactory function. Both objective 
and subjective examinations are used to evaluate the 
sense of smell. 
Subjective examinations are based on olfactory 
tests that are commonly used in modern clinical stud-
ies. They include:
 — Sniffin’ Sticks — a test comprised of three parts: 
olfactory threshold (OT), odour discrimination (OD), 
and odour identification (OI). The tested person 
can receive a score of 0-16 points. The OT test 
is performed using 16 different concentrations of 
n-butanol. The tested person, given a set of three 
sticks — two odourless, one with n-butanol — has to 
indicate the one with n-butanol. The lowest concen-
tration where the tested person can smell n-butanol 
is the olfactory threshold. Within a given concentra-
tion, n-butanol has to be correctly indicated at least 
two times. In the OD test, the tested person has to 
indicate the stick with the odour different from the 
two other sticks. The test is performed using 16 sets 
of sticks. In case of the OI test, the tested person has 
to choose the correct odour from among the four 
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possible answers given. Sixteen odours are tested. 
The total score that can be given for the entire test is 
48 points [3,12,15–16]. Sniffin’ Sticks are considered 
to be a test with the highest sensitivity because they 
test all of the three functional aspects of the sense of 
smell (olfactory threshold, odour discrimination, and 
odour identification). Deviations considered to bear 
statistical significance in the TDI test are deviations 
of more than 5.5 points in the follow-up test [3].
 — The University of Pennsylvania Smell Identification 
Test (UPSIT) is the most common and the best 
available identification test [16]. This test involves 
identification of 40 odorants on scratched strips by 
choosing the correct names of smells from among 
the four possible answers given. This test allows 
determination of the extent of olfactory damage 
and detection of malingerers. The probability theory 
and, to a lesser degree, the use of odour perceived 
by nerves other than the olfactory nerve, are both 
used to detect malingerers. By choosing random 
answers, the persons who truly cannot sense smells 
will correctly indicate an average of 25% of odours, 
scoring 10 out of 40 possible points [5,12,16].
 — Cross-Cultural Smell Identification Test (CCSIT), 
also called the Brief Smell Identification Test (BSIT). 
This test is also based on odour identification but 
includes only 12 smells. The odours used are well-
known irrespective of cultural tradition in a given 
region of the world. Thereby, the probability of indi-
cating a smell incorrectly due to an unfamiliar name 
of a given substance has been greatly reduced. As 
it is easy to perform, its cost is low, and its duration 
is short; the test is used as a screening test. 
 — Even more simplified identification tests have been 
described in the literature. In such tests there are 
only seven smells, separate for each nasal cavity 
[7,17–18]. The patient has to choose the correct 
answer after being presented with four possible 
answers [7,17,–18].
 — Butanol Threshold Test (BTT) is a test where the 
odour detection threshold is tested, the odour is 
usually n-butanol in nine different concentrations 
between 0.00061% and 4%. The patient, being pre-
sented with two vials on a random basis (one with 
n-butanol and one with pure water), has to indicate 
the one with the stronger smell. The test begins with 
the lowest concentration of the tested substance. 
The concentration of n-butanol in each subsequent 
vial is three times higher than the concentration in 
the previous one. The odour detection threshold is 
the lowest concentration at which n-butanol can be 
detected. At least four successive correct answers 
[7,12,17,19–20] or five correct answers [16] have 
to be given for a particular concentration. Other 
odorants, such as peppermint oil, lemon oil, clove 
oil, or ethyl acetate, can be used in the test as well 
[17]. The test can be used to diagnose hyposmia 
[19]. Its advantage is short duration time — usually 
about five minutes [19]. The sensitivity of the test is 
comparable to that of CCSIT. 
 — Self-Administered Odour Questionnaire (SAOQ). 
In this test, the patient tells whether he/she can 
smell 20 odours: steamed rice, miso, seaweed, soy 
sauce, baked bread, butter, curry, garlic, orange, 
strawberry, green tea, coffee, chocolate, household 
gas, garbage, timber, excrement, sweat, a flower, 
and perfume. In case an odour is smelled strongly, 
a score of 2 is assigned, for faint smell 1 point is 
assigned, and if no odour is smelled or the odour is 
unknown, no points are assigned. The result is not 
taken into account if the patient cannot recognise 
more than 10 odours [21].
 — Intravenous olfaction test: prosultiamine, corre-
sponding to the smell of garlic, or thiamine propyl 
disulphide, corresponding to the smell of onion, is 
administered into a forearm vein. A dose of 10 mg 
of thiamine propyl disulphide is administered within 
10 s [10]. The test outcome is positive if the patient 
states that he/she can smell a given odour; if not, 
the outcome is negative.
 — Takagi and Toyota (T&T) olfactometer test — five 
odours are tested: phenethyl alcohol (rose), methyl 
cyclopentenolone (caramel), isovaleric acid (sweat), 
gamma-undecalactone (peach), and skatole 
(thrash) [10,21].
 — Visual Analogue Scale (VAS), mentioned previously, 
in which the patient self-assesses the sense of smell 
using an analogue scale, is also in common use, 
with 0 mm corresponding to anosmia and 100 mm 
corresponding to a perfect sense of smell. The test 
result is the length from 0 to 100 mm on the scale. 
The test is solely based on subjective assessment by 
the patient, without the use of any odorants [16,20].
The second group of olfactory tests are objective 
examinations where magnetic resonance imaging 
(MRI), positron emission tomography (PET), olfactory 
event-related potentials (OERPs), and olfactory en-
sheathing glial cells (OEGs) are used [22]. However, 
due to the high cost and limited availability of these 
tests, objective olfaction assessment methods are used 
only occasionally.
To evaluate the impact of sense of smell disturbanc-
es on quality of life there are several questionnaires, the 
most popular are described as follows: The Sinonasal 
Outcome Test (SNOT-22) is comprised of 22 ques-
tions evaluated according to a Likert-type scale of 0–5, 
where 0 is indicative of absence of the symptom, and 
5 means that the symptom is very onerous. A total score 
of 110 can be achieved. Less detailed questionnaires 
including 20 questions (SNOT-20) are sometimes used. 
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The SNOT-22 questionnaire is used to evaluate the 
four cardinal symptoms of CRS. Question 6 asks about 
evaluate facial pain/pressure, question 10 — nasal 
blockage, question 21 — function of the sense of smell 
and taste, and question 22 runny nose. [18,23]
Rhinosinusitis Disability Index (RSDI) — includes 
a total of 30 statements evaluated according to a Likert-
type scale of 0–4, where 0 means ‘never’ and 4 means 
‘always’. A total score of 120 can be achieved. Eleven 
statements are used to evaluate the physical condition, 
nine statements — the functional condition, and ten 
statements — the emotional condition. From the view-
point of evaluating main symptoms of CRS, the most 
significant questions are: no. 1 — ‘The pain or pressure 
in my face makes it difficult for me to concentrate’, no. 
6 — ‘I am inconvenienced by my chronic runny nose’, 
no. 7 — ‘Food does not taste good because of my 
change in smell’, and no. 10 — ‘I have difficulty with 
exertion due to my nasal obstruction’ [18,23].
Questionnaire of Olfactory Disorder (QOD) — the 
test is comprised of three modules:
Questionnaire of Olfactory Disorder — negative 
statements (QOD — NS) — includes 17 negative state-
ments. Each of them is assigned a score of 0 — 3 by 
the tested person. A total score of 51 can be achieved. 
Higher score is equivalent to better quality of life. This 
module is used to evaluate the extent to which dysosmia 
affects everyday life. The two other modules: Ques-
tionnaire of Olfactory Disorder — positive statements 
(QOD — PS) — two statements, and Questionnaire of 
Olfactory Disorder — socially desired statements (QOD 
— SD) — six statements; these last two modules are 
both of lesser significance as far as evaluation of the 
quality of life is concerned [23–25]. 
The effect of the polyps on the sense  
of smell
In recent years there have been many original 
articles published focusing on the comparison of the 
effect of treatment of CRS versus conservative therapy 
on improvement in olfactory function and the asso-
ciated improvement in the patient’s quality of life. In 
the overwhelming majority of clinical studies, patients 
were qualified according to EPOS 2009- and EPOS 
2012-based criteria. The patients were usually divided 
into two groups, following the abovementioned guide-
lines, depending on the presence of nasal polyps, as: 
CRSwNP and CRSsNP. 
One study including 113 patients showed that, within 
the period of six months following FESS surgery, greater 
improvement in the sense of smell was achieved by 
patients from the CRSwNP group as compared to those 
from the CRSsNP group. Improvement in the sense of 
smell based on the UPSIT test was found in 72.5% of 
patients from the CRSwNP group, aggravation in 13.7% 
of patients, and no change in 13.7% of patients [5]. The 
results provided above suggest that the presence of na-
sal polyps, obstruction of nasal meatuses by these pol-
yps, and subsequent reduced inflow of odorants to the 
olfactory epithelium are all of fundamental significance 
in the pathophysiology of dysosmia. These conclusions 
were confirmed in a subsequent study where the pa-
tients were divided into two groups: group A, where the 
polyps were surgically removed, and group B, where the 
polyps were left intact. In group A, after six months of 
FESS, a statistically significant improvement of UPSIT, 
SNOT-20, and VAS results was found, whereas in group 
B significant improvement was found only in the VAS 
test. It was thereby confirmed that surgical removal of 
nasal polyps has an effect on improvement of the sense 
of smell [14]. The same conclusions were reached in 
a study covering 342 patients, in which improvement of 
the sense of smell was greater in patients with CRSwNP 
than in patients with CRSsNP. CT scans were assessed 
according to the Lund-Mackay scoring system, nasal 
endoscopy results — according to the Lund-Kennedy 
scoring system, and the SNOT-22 questionnaire was 
evaluated, all prior to the surgery and six months after 
the surgery. Surprisingly, in those patients with the best 
improvement in all four cardinal symptoms of CRS, the 
level of the sense of smell improvement was the lowest. 
It might be caused by the fact that only a small number 
of patients had been aware of olfactory dysfunctions 
[26]. It was reported by Kim et al. that only 58% of pa-
tients were aware of dysosmia before smell tests [19]. 
Similar conclusions were drawn based on observations 
made six months after FESS surgery. In this specific 
case, the sense of smell was tested using the TDI test 
in patients treated for CRSwNP. The observed improve-
ment in the sense of smell was worse than that found 
in the previous studies, and was seen in 42% of cases, 
with the treatment having no impact on the sense of 
smell observed in 53% of the subjects, and the sense 
of smell being aggravated in 5% of the subjects [3].
To evaluate how age affects the main symptoms of 
CRS, three age groups were identified among persons 
suffering from this disease. It was found that in the group 
of patients below 40 years of age dysosmia is the most 
uncommon — affecting 37.0% of the studied group. At 
the same time, the CRSsNP variant was found to prevail 
in this group of patients. On the other hand, CRSwNP is 
more common in the 40–59-year-old age group and in 
patients older than 60 years. In addition, the percentage 
of dysosmias increases with age: it is equal to 49.8% 
and 53.1% for the middle-aged group and the oldest 
age group, respectively, which constitutes yet another 
confirmation of the fact that the presence of nasal polyps 
affects the condition of the sense of smell [27].
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Table 1. CT score by Lund Mackay scale [8]
Scoring
Structure
0 1 2
Maxillary sinus no abnormalities or absent partial opacification total opacification
Frontal sinus
Anterior ethmoidal sinus
Posteriori ethmoidal sinus
Sphenoidal sinus
Ostiomeatal complexes non-occluded occluded
Table 2. Nasal endoscopy score by Lund Kennedy scale [8]
Scoring
Appearances
0 1 2
Polyp
absent
polyps in middle meatus only polyps beyond middle meatus
Discharge clear, thin thick, purulent
Oedema
mild severeScarring
Crusting
Table 3. Interpretation of olfaction test results
Research
Olfaction  
condition
TDI [25] UPSIT  
[16]
CCSIT [13] BSIT BTT [13] SAOQ [21] olfactometer 
T&T  
[10,21]
Anosmia 0-15
depending  
on age
0-3 0-4 [19] 0-1  
 
0-28
5,6-5,8
 
Hyposmia
severe 16–34,5 4-5  
5-8 [19]
2-3 4,2-5,4
moderate 6-8 4-5 2,6-4,0
mild 9-10 6-7 1,2-2,4
Normosmia 35-48 11-12 9-11  
[18,19,23]
8-9 29-40 0-1,0
TDI — Sniffin’ Sticks assess the olfactory threshold, discrimination, and identification; UPSIT — University of Pennsylvania Smell Identification 
Test; CCSIT — Cross-Cultural Smell Identification Test; BSIT - Brief Smell Identification Test; BTT — Butanol Threshold Test; SAOQ — Self-
Administrated Odour Questionnaire; T&T — olfactometer (stands for Takagi and Toyota)
The healing of post-operative wounds 
and improvement in olfactory function
Another paper aimed to find factors, other than 
removal of nasal polyps, that improve the sense of 
smell in CRSwNP patients. They focused on the local 
condition after surgical treatment in 50 patients. In order 
to carry out this evaluation, the patients were divided 
into two groups: the group in which wound healing 
was good according to endoscopy result assessment 
using the Lund Kennedy scoring system, and the group 
with local postoperative complications. By analysing 
the endoscopy results and the CT scans according to 
the Lund Mackay scoring system, and performing BTT 
and CCSIT tests, greater post-operative improvement 
in the sense of smell was found in patients with proper 
wound healing as compared with those with local 
postoperative complications. In addition, it was noted 
that in patients who did not show improvement in the 
sense of smell despite good wound healing, severity of 
dysosmia before FESS was greater, as well as pre-op-
erative changes seen in the CT scan. It is very likely 
that the cause is partial or total damage to the olfactory 
epithelium. It was concluded that pre-operative CT scan 
analysis according to the Lund Mackay scoring system 
and post-operative observation of the local condition 
of the wound (short term — swelling and inflammation, 
long term — scars, recurrence of polyps) can be used 
to predict post-operative improvement in the sense 
of smell [13].
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The role of CT and mrI scans serving as 
prognostic indicators of improvement in 
the sense of smell
In a study by Soler et al., comprising 121 patients, 
CT scan analysis according to the Lund Mackay scoring 
system was used, but the UPSIT method of olfactory 
assessment and the method of QOL (Quality of Life) 
assessment were modified by using a different question-
naire — the QOD–NS. The post-operative assessment 
period covered the six months immediately after the 
procedure. In this case, the CT scan allowed prediction 
of QOL improvement correlated with the sense of smell 
by using QOD–NS, with the improvement percentage 
being 53%. However, QOD–NS was not correlated with 
UPSIT, probably due to the fact that odour identification 
is not the only component of the sense of smell affecting 
the quality of life [23].
Quite different conclusions were arrived at in a study 
covering 153 patients suffering from CRS. The results 
were based on the following tests: endoscopy, UPSIT, 
and smell self-assessment surveys — before the sur-
gery, 3-6 months after FESS, and 12 months after FESS. 
The results were compared with CT scans scored using 
the Lund Mackay system. No correlation between the 
Lund Mackay scores of the CT scans and improvement 
in the sense of smell was found [28].
An original clinical study was carried out on a group 
of 31 patients. The study involved assessment of head 
MRI scans and TDI tests before FESS and three months 
after surgery. The aim of the study was to show changes 
in the white matter of the central nervous system. The 
hypothesis was based on previous confirmed findings 
pertaining to volumetric changes in the olfactory bulb 
and grey matter of the olfactory cortex and to plasticity 
of these areas associated with improvement in the 
sense of smell. Before the surgery, 36% of the patients 
were anosmic, 45% were hyperosmic, and 19% were 
normosmic, i.e. had normal olfactory function. Average 
improvement after FESS was 9.06%. The patients were 
divided into two groups: one with significant olfactory 
function improvement (38.71%) and one without sig-
nificant olfactory function improvement. It was found 
in the case of the group with significant olfactory func-
tion improvement that there is a close correlation with 
radiographic MRI analysis of structural changes in the 
left anterior area of the cingulate gyrus and the right 
amygdala [15].
In order to link instrumental examinations with the 
achieved results of tests for olfaction and quality of life 
related thereto, a new endoscopy scale — the “Olfactory 
Cleft Endoscopy Scale” (OCES) — has been developed 
[24]. This method is designed for post-operative mon-
itoring of the local condition with the use of the same 
type of endoscope as the one used during the proce-
dure. The evaluation covers five factors, each given 
a score of 0–2: presence of discharge, swelling, polyps, 
crusting, and scarring. Each side is evaluated separate-
ly. Therefore, the maximum total score is 20. This scale 
was validated in a group of 38 patients and was found 
to correlate with TDI and QOD–NS.
The effect of time after the procedure 
on the condition of the sense of smell
The degree of smell impairment before starting 
therapy, either surgical or conservative, affects prog-
nosis. The more severe the olfactory dysfunction was 
before surgical treatment, the greater the statistical 
improvement of the sense of smell as a result of the 
administered treatment will be. However, in the most 
extreme cases, i.e. in the group of patients who had 
been diagnosed with very severe olfactory dysfunction 
before FESS, even aggravation of olfactory function 
after the surgery was noted [28].
In a study based on early outcomes achieved one 
and three months after FESS, a gradual decrease in the 
percentage of patients with dysosmias, from 70% before 
the surgery to 22.5% one month after the procedure and 
then to 10% of subjects within three months after the 
procedure, was shown by means of BTT. Furthermore, 
improvements in both the VAS scale results and Lund 
Mackay endoscopy scoring results were observed [17]. 
A broader analysis of the prevalence and severity 
of symptoms was conducted in another study involving 
62 patients. Remission of all four cardinal symptoms of 
CRS was observed in all patients. Improvement in the 
sense of smell in the period immediately following the 
procedure was found in 96.3% of cases. In the same 
study, follow-up examinations were conducted at 1, 3, 
6, 12, and 24 months after FESS. Dysosmia was re-
vealed to be an early sign of recurrence of nasal polyps, 
whereas nasal obstruction and facial pain were found 
to be late symptoms of recurrence of nasal polyps [29].
A similar post-operative period was analysed in 
another study in which two timeframes were taken 
into account: 6-12 months after the procedure and 12-
24 months after FESS [30]. Both Lund Mackay-scored 
CT and nasal endoscopy were conducted before the 
procedure. It was proven that improvement in the sense 
of smell can barely be predicted based on pre-operative 
examination. The abovementioned objective tests were 
poorly correlated with subjective olfactory tests related 
to QOL improvement.
A unique study assessed long-term outcomes of 
CRS treatment in 45 patients. In the study course the 
olfaction tests were carried out at three months and five 
years after the FESS surgery. The results were based 
on VAS, BTT, and smell tests. In the five-year period, 
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the sense of smell as measured in the abovementioned 
tests was improved by 79%, 85%, and 53%, respective-
ly. Significant improvement was observed for both early 
and long-term treatment outcomes. Even though test 
results five years after the surgery were worse when 
compared to results after three months, no significant 
worsening of results between these two periods was 
found [12].
Comparison of various types of 
olfactory tests
A study by Kim et al. aimed to find the best olfactory 
test methods, as well as the usefulness of BSIT in com-
parison with BTT. The study was conducted in a group 
of 68 patients before surgical treatment and six months 
after treatment by means of the two tests and a VAS 
scale. The results showed that BSIT can replace BTT. 
The latter is methodologically better; on the other hand, 
the advantages of BSIT are shorter duration of the test 
and the fact that the staff do not need to be provided 
with special training. Sensitivity of BSIT was deemed to 
be 63.8%, while its specificity was 93.8%. In addition, 
in the case of 83.0% of patients suffering from olfactory 
dysfunction, 41.2% achieved improvement in the sense 
of smell, 25.0% noted aggravation of this sense, and in 
33.8% the sense of smell remained unchanged [19].
The role of conservative treatment
In order to optimise post-operative care, the effect 
of irrigation on olfactory function and the quality of life 
was studied in 110 patients [31]. Subjects were divided 
into three groups: the no irrigation group, the water 
irrigation group, and the ionised acidic water irrigation 
group (such water shows antibacterial activity). UPSIT 
and SNOT-20 tests were conducted within each group 
before FESS and three months after the procedure. 
Significant improvement in patients’ condition was ob-
served in each group, but the improvement was greater 
in groups where irrigation was used [31].
Budesonide irrigation after FESS has also been 
studied. For this purpose, patients treated for CRSwNP 
with FESS were divided into two groups: one treated 
with sodium chloride (NaCl) irrigations and one treated 
with NaCl and budesonide irrigations, and subjected to 
UPSIT, phenethylamine (PEA) test, SNOT-22, Rhinosi-
nusitis Outcome Measure (RSOM) 31, and the RSDI 
test four times, including three times after the surgical 
procedure (1–2 weeks after the procedure, 3-8 weeks 
after the procedure, and 3–6 months after the proce-
dure). Improvement in the quality of life was found to 
be similar in the two groups [32].
A significant impact of sense of smell improvement on 
quality of life and mental health was confirmed. The TDI 
test, QOD questionnaires, and other mental health assess-
ment scales, including the Beck Depression Inventory, 
were used for this purpose [25]. In a study employing BSIT 
for assessment of the sense of smell in 5445 patients, no 
close correlation with scores recorded in the SNOT and 
RSDI questionnaires evaluating the quality of life were 
found. This might be related to the low sensitivity of BSIT 
associated with its limited capability of differentiating the 
degree of olfactory dysfunction. This claim is supported 
by the low percentage of dysosmia recorded in the study, 
amounting to 28.3%. Nevertheless, the significant cor-
relation between severity of olfactory impairment and CT 
scan evaluation according to the Lund Mackay system, 
as well as nasal endoscopy result evaluation according 
to the Lund Kennedy system, was still confirmed [18].
Even if primary pharmacological treatment is unsuc-
cessful, not all patients are chosen to undergo surgical 
treatment, regardless of indications for the procedure. 
The impact of surgical treatment on the sense of smell 
was evaluated by comparing the group of patients who 
had undergone surgical treatment with the group of 
patients who had continued their pharmacological treat-
ment. Primary pharmacological treatment was associat-
ed with no effect in both groups. The first group covered 
80% of patients, while the second group covered 20%. 
BSIT, RSDI, and SNOT-22 tests were repeated after six 
months; in the case of the surgical treatment group, 
the first tests were performed before FESS. A total of 
280 patients were tested. As far as the first group is 
concerned, improvement in the sense of smell was 
observed in 66 patients (41.2%). As for the second 
group, improvement was found in 17 cases (37.9%). 
Comparable improvement was shown in both groups 
irrespective of the presence of polyps. As regards the 
patients diagnosed with CRSwNP, correlation between 
olfactory improvement and nose patency improvement 
was shown, whereas in case of the patients diagnosed 
with CRSsNP, correlation between olfactory improve-
ment and reduction of nasal discharge was shown. 
Patients with normosmia were found not to suffer from 
olfactory impairment after treatment [23].
Eosinophilic rhinosinusitis
A somewhat different method of CRS classification 
has been developed in Japan in the Japanese Epide-
miological Survey of Refractory Eosinophilic Chronic 
Rhinosinusitis Study (JESREC study). CRS is classified 
as eosinophilic chronic rhinosinusitis (ECRS) on the 
basis of assessment regarding the presence of: nasal 
obstruction with dysosmia (score 0–3), polyps on both 
sides of the middle nasal meatus (score 0–2), eosino-
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phils (score 0–10), and ethmoid cells bilateral shadow in 
CT (score 0–2). A score of 11 or higher is equivalent to 
diagnosis of ECRS, while a score of less than 11 means 
non-eosinophilic chronic rhinosinusitis (NECRS) [10,21].
The classification system presented above was 
applied to 57 patients tested by means of SNOT-22, 
Patient-Reported Outcomes Measurement Information 
System (PROMIS) 29, and quality of life (QOL) question-
naires [33]. The discussed study proved that patients 
suffering from ECRS experience more onerous smell 
and taste impairments, nasal obstruction, and nasal 
congestion than those suffering from NECRS. Among 
the group of 27 patients with ECRS, 21 were diagnosed 
with CRSwNP, while the rest, with CRSsNP, according 
to the EPOS criteria.
Another Japanese study employed the intravenous 
olfaction test and T&T olfactometer testing [20]. In 
a group of 272 patients, 193 were classified as ECRS 
patients and 79 as NECRS patients. Correlation between 
occurrence of dysosmia defined by certain olfactory 
threshold values and results of CT scanning defined by 
nose and paranasal sinuses shadowing were found. In 
the group of patients suffering from ECRS, dysosmia 
is more severe and takes the form of anosmia, while 
in the case of NECRS, hyposmia is dominant [10]. 
Another study covering a group of 89 patients and 
a longer post-operative period, with patients divided 
into ECRS-diagnosed and NECRS-diagnosed patients, 
was conducted. In this study, the SAOQ test as well as 
VAS and T&T tests were performed before FESS and 
3, 6, 12, and 24 months after the procedure. Average 
improvement in the sense of smell was achieved within 
six months of the procedure (including 50–60% of anos-
mic patients noticing improvement within half a year). It 
was shown that eosinophilia is a predisposing factor of 
olfactory dysfunction because eosinophilic infiltration in 
the olfactory epithelium leads to sensory impairment. In 
cases where eosinophilia is severe, one has to expect 
dysosmias to recur.
Other factors affecting the sense of smell
As tobacco smokers have a poorer sense of smell, 
the researchers decided to analyse the impact of smok-
ing on improvement in the quality of life after surgical 
treatment (FESS). A group of 111 patients took part 
in the study; their CT scans were analysed according 
to the Lund Mackay scoring system, and their nasal 
endoscopy results — according to the Lund Kennedy 
system; they were also subjected to an olfactory test 
and filled in the QOD questionnaire. All examinations 
were performed before the procedure and 12 months 
after the procedure [34]. It was found that improvement 
in the quality of life was present in both smokers and 
non-smokers, but the degree of improvement was much 
better in non-smokers.
It was demonstrated that aspirin sensitivity or lack 
of aspirin sensitivity had no impact on olfactory dys-
function in CRS [35].
Conclusions
1. The extent of changes in chronic rhinosinusitis with 
polyps is detrimental to olfactory function.
2. Dysosmia is the least onerous of the four cardi-
nal symptoms.
3. Improvement in the sense of smell is correlated with 
proper surgical wound healing.
4. Irrigation can be used as a useful element of olfacto-
ry organ treatment, with pharmacological treatment 
and surgical treatment having a similar effect. 
5. Prognosis of improvement in the sense of smell is 
worse in ECRS. 
6. Tobacco smoking also aggravates the prognosis of 
improvement in olfactory function.
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